166 related articles for article (PubMed ID: 25456867)
1. Effects of Prolastin C (Plasma-Derived Alpha-1 Antitrypsin) on the acute inflammatory response in patients with ST-segment elevation myocardial infarction (from the VCU-alpha 1-RT pilot study).
Abbate A; Van Tassell BW; Christopher S; Abouzaki NA; Sonnino C; Oddi C; Carbone S; Melchior RD; Gambill ML; Roberts CS; Kontos MC; Peberdy MA; Toldo S; Vetrovec GW; Biondi-Zoccai G; Dinarello CA
Am J Cardiol; 2015 Jan; 115(1):8-12. PubMed ID: 25456867
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting the Inflammatory Injury After Myocardial Ischemia Reperfusion With Plasma-Derived Alpha-1 Antitrypsin: A Post Hoc Analysis of the VCU-α1RT Study.
Abouzaki NA; Christopher S; Trankle C; Van Tassell BW; Carbone S; Mauro AG; Buckley L; Toldo S; Abbate A
J Cardiovasc Pharmacol; 2018 Jun; 71(6):375-379. PubMed ID: 29634656
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.
Di Stefano R; Di Bello V; Barsotti MC; Grigoratos C; Armani C; Dell'Omodarme M; Carpi A; Balbarini A
Biomed Pharmacother; 2009 Dec; 63(10):773-80. PubMed ID: 19906505
[TBL] [Abstract][Full Text] [Related]
4. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
Foussas SG; Zairis MN; Lyras AG; Patsourakos NG; Tsirimpis VG; Katsaros K; Beldekos DJ; Handanis SM; Mytas DZ; Karidis KS; Tselioti PG; Prekates AA; Ambrose JA
Am J Cardiol; 2005 Aug; 96(4):533-7. PubMed ID: 16098307
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy-associated plasma protein A: a biomarker in acute ST-elevation myocardial infarction (STEMI).
Lund J; Qin QP; Ilva T; Nikus K; Eskola M; Porela P; Kokkala S; Pulkki K; Pettersson K; Voipio-Pulkki LM
Ann Med; 2006; 38(3):221-8. PubMed ID: 16720436
[TBL] [Abstract][Full Text] [Related]
6. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]).
Lim P; Moutereau S; Simon T; Gallet R; Probst V; Ferrieres J; Gueret P; Danchin N
Am J Cardiol; 2013 Jan; 111(1):31-7. PubMed ID: 23062316
[TBL] [Abstract][Full Text] [Related]
9. Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation.
Canale ML; Stroppa S; Caravelli P; Petronio AS; Mariotti R; Mariani M; Balbarini A; Barsotti A
Coron Artery Dis; 2006 Dec; 17(8):693-8. PubMed ID: 17119378
[TBL] [Abstract][Full Text] [Related]
10. Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.
Chen YG; Xu F; Zhang Y; Ji QS; Sun Y; Lü RJ; Li RJ
Chin Med J (Engl); 2006 Jan; 119(1):32-6. PubMed ID: 16454979
[TBL] [Abstract][Full Text] [Related]
11. Association between C-reactive protein level and echocardiography assessed left ventricular function in first ST-segment elevation myocardial infarction patients who underwent primary coronary intervention.
Shacham Y; Topilsky Y; Leshem-Rubinow E; Arbel Y; Ben Assa E; Keren G; Roth A; Steinvil A
J Cardiol; 2014 Jun; 63(6):402-8. PubMed ID: 24299986
[TBL] [Abstract][Full Text] [Related]
12. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial.
Théroux P; Armstrong PW; Mahaffey KW; Hochman JS; Malloy KJ; Rollins S; Nicolau JC; Lavoie J; Luong TM; Burchenal J; Granger CB
Eur Heart J; 2005 Oct; 26(19):1964-70. PubMed ID: 15872036
[TBL] [Abstract][Full Text] [Related]
14. A Preclinical Translational Study of the Cardioprotective Effects of Plasma-Derived Alpha-1 Anti-trypsin in Acute Myocardial Infarction.
Mauro AG; Mezzaroma E; Marchetti C; Narayan P; Del Buono MG; Capuano M; Prestamburgo A; Catapano S; Salloum FN; Abbate A; Toldo S
J Cardiovasc Pharmacol; 2017 May; 69(5):273-278. PubMed ID: 28195949
[TBL] [Abstract][Full Text] [Related]
15. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
[TBL] [Abstract][Full Text] [Related]
16. Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction.
Terlecki M; Bednarek A; Kawecka-Jaszcz K; Czarnecka D; Bryniarski L
Kardiol Pol; 2013; 71(3):260-7. PubMed ID: 23575781
[TBL] [Abstract][Full Text] [Related]
17. Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51).
Mega JL; Braunwald E; Murphy SA; Plotnikov AN; Burton P; Kiss RG; Parkhomenko A; Tendera M; Widimsky P; Gibson CM
J Am Coll Cardiol; 2013 May; 61(18):1853-9. PubMed ID: 23500262
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study).
Abbate A; Kontos MC; Grizzard JD; Biondi-Zoccai GG; Van Tassell BW; Robati R; Roach LM; Arena RA; Roberts CS; Varma A; Gelwix CC; Salloum FN; Hastillo A; Dinarello CA; Vetrovec GW;
Am J Cardiol; 2010 May; 105(10):1371-1377.e1. PubMed ID: 20451681
[TBL] [Abstract][Full Text] [Related]
19. Prognostic usefulness of serial C-reactive protein measurements in ST-elevation acute myocardial infarction.
Makrygiannis SS; Ampartzidou OS; Zairis MN; Patsourakos NG; Pitsavos C; Tousoulis D; Prekates AA; Foussas SG; Cokkinos DV
Am J Cardiol; 2013 Jan; 111(1):26-30. PubMed ID: 23040593
[TBL] [Abstract][Full Text] [Related]
20. [Effect of the early administration of pravastatin on C-reactive protein and interleukin-6 levels in the acute phase of myocardial infarction with ST segment elevation].
Gonzálvez M; Ruiz Ros JA; Pérez-Paredes M; Lozano ML; Giménez DM; Martínez-Corbalán F; Carnero A; Cubero T; Gómez AE; Vicente V
Rev Esp Cardiol; 2004 Oct; 57(10):916-23. PubMed ID: 15469788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
